Keyphrases
Methionine
100%
Fibroblast Growth Factor 21 (FGF21)
100%
Choline-deficient
100%
Nonalcoholic Steatohepatitis
100%
Endoplasmic Reticulum Stress (ER stress)
36%
Peroxisome Proliferator-activated Receptor
27%
Diet-induced
18%
Null Mice
18%
Non-alcoholic Fatty Liver Disease (NAFLD)
18%
Genotype
9%
Lipids
9%
MRNA Level
9%
Liver
9%
C57BL
9%
Possible Mechanisms
9%
No Significant Difference
9%
Wild Mice
9%
Palmitoyl-CoA
9%
Inducer
9%
Coactivator
9%
DNA Damage
9%
Diacylglycerol
9%
Diet Therapy
9%
Primary Hepatocytes
9%
L-carnitine
9%
Palmitic Acid
9%
Energy Homeostasis
9%
Adipose Triglyceride Lipase
9%
Lipid Phosphatase
9%
Cluster of Differentiation 36 (CD36)
9%
Receptor-independent
9%
Farnesoid X Receptor
9%
Stress-related Growth
9%
White Adipose Tissue
9%
Lipid Clearance
9%
Hepatic Fat
9%
Phosphatase 2A
9%
Adipocyte Lipolysis
9%
Pharmacology, Toxicology and Pharmaceutical Science
Methionine
100%
Nonalcoholic Fatty Liver
100%
Choline
100%
Nutritional Deficiency
100%
Fibroblast Growth Factor 21
100%
Peroxisome Proliferator Activated Receptor
42%
Knockout Mouse
28%
Fatty Acid
14%
Wild Type Mouse
14%
Transferase
14%
Triacylglycerol
14%
Palmitic Acid
14%
Liver Disease
14%
Farnesoid X Receptor
14%
Pancreatic Lipase
14%
Carnitine
14%
Diacylglycerol
14%
Palmitoyl-CoA
14%
Growth Arrest and DNA Damage Inducible Protein 153
14%
Medicine and Dentistry
FGF21
100%
Methionine/Choline Deficient Diet
100%
Nonalcoholic Fatty Liver
100%
Endoplasmic Reticulum Stress
57%
Peroxisome Proliferator Activated Receptor
42%
Adipose Tissue
28%
Non-Alcoholic Fatty Liver Disease
28%
Homeostasis
14%
Diet Therapy
14%
Upregulation
14%
Triacylglycerol
14%
Hepatocyte
14%
Liver Disease
14%
Lipid Storage
14%
Farnesoid X Receptor
14%
Lipolysis
14%
Triacylglycerol Lipase
14%
Transferase
14%
Palmitic Acid
14%
Growth Arrest and DNA Damage Inducible Protein 153
14%
Carnitine
14%
Diacylglycerol
14%